A carregar...
Challenges in the clinical utility of the serum test for HER2 ECD
Approximately 15–30% of breast cancers over-express the HER2/neu receptor. Historically, over-expression of HER2/neu has been identified using IHC or FISH, both of which are invasive approaches requiring tissue samples. Recent evidence has shown that some tumors identified as “negative” using these...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2012
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3362659/ https://ncbi.nlm.nih.gov/pubmed/22521738 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbcan.2012.03.012 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|